Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas. more
Time Frame | BIAF | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.04% | -1.8% | -0.77% |
1-Month Return | -28.19% | -3.48% | 0.71% |
3-Month Return | -46.34% | -7.2% | 8.81% |
6-Month Return | -56.78% | -1.54% | 12.32% |
1-Year Return | -31.29% | 8.39% | 30.57% |
3-Year Return | -88.49% | 6.07% | 29.21% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | 1.31K | 4.80K | 2.53M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.05,"profit":true},{"date":"2022-12-31","value":0.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 40.28K | 22.24K | 4.82K | 467.00 | 1.74M | [{"date":"2019-12-31","value":2.31,"profit":true},{"date":"2020-12-31","value":1.28,"profit":true},{"date":"2021-12-31","value":0.28,"profit":true},{"date":"2022-12-31","value":0.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (40.28K) | (22.24K) | (4.82K) | 4.34K | 791.62K | [{"date":"2019-12-31","value":-5.09,"profit":false},{"date":"2020-12-31","value":-2.81,"profit":false},{"date":"2021-12-31","value":-0.61,"profit":false},{"date":"2022-12-31","value":0.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | - | - | (368.84%) | 90.28% | 31.26% | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-408.56,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":34.62,"profit":true}] |
Operating Expenses | 3.05M | 2.60M | 2.21M | 4.02M | 8.76M | [{"date":"2019-12-31","value":34.82,"profit":true},{"date":"2020-12-31","value":29.71,"profit":true},{"date":"2021-12-31","value":25.18,"profit":true},{"date":"2022-12-31","value":45.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (3.09M) | (2.60M) | (2.21M) | (4.01M) | (7.97M) | [{"date":"2019-12-31","value":-309224000,"profit":false},{"date":"2020-12-31","value":-260438500,"profit":false},{"date":"2021-12-31","value":-220682200,"profit":false},{"date":"2022-12-31","value":-401105800,"profit":false},{"date":"2023-12-31","value":-797322800,"profit":false}] |
Total Non-Operating Income/Expense | - | (5.04M) | (5.12M) | (6.63M) | 104.54K | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-4823.84,"profit":false},{"date":"2021-12-31","value":-4896.9,"profit":false},{"date":"2022-12-31","value":-6338.93,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (3.30M) | (7.27M) | (6.32M) | (8.15M) | (7.92M) | [{"date":"2019-12-31","value":-330429900,"profit":false},{"date":"2020-12-31","value":-726598700,"profit":false},{"date":"2021-12-31","value":-632446300,"profit":false},{"date":"2022-12-31","value":-815165400,"profit":false},{"date":"2023-12-31","value":-791601800,"profit":false}] |
Income Taxes | 3.20K | 2.75K | 1.95K | 2.46K | 20.99K | [{"date":"2019-12-31","value":15.24,"profit":true},{"date":"2020-12-31","value":13.1,"profit":true},{"date":"2021-12-31","value":9.29,"profit":true},{"date":"2022-12-31","value":11.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | - | (7.27M) | (6.33M) | (8.15M) | (7.94M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-726873700,"profit":false},{"date":"2021-12-31","value":-632641300,"profit":false},{"date":"2022-12-31","value":-815411300,"profit":false},{"date":"2023-12-31","value":-793701100,"profit":false}] |
Income From Continuous Operations | - | (7.27M) | (6.33M) | (8.15M) | (7.24M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-726873700,"profit":false},{"date":"2021-12-31","value":-632641300,"profit":false},{"date":"2022-12-31","value":-815411300,"profit":false},{"date":"2023-12-31","value":-723843000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (3.31M) | (7.27M) | (6.33M) | (8.15M) | (7.94M) | [{"date":"2019-12-31","value":-330749900,"profit":false},{"date":"2020-12-31","value":-726873700,"profit":false},{"date":"2021-12-31","value":-632641300,"profit":false},{"date":"2022-12-31","value":-815411300,"profit":false},{"date":"2023-12-31","value":-793701100,"profit":false}] |
EPS (Diluted) | - | - | - | (1.29) | (0.64) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-129,"profit":false},{"date":"2023-12-31","value":-64,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BIAF | |
---|---|
Cash Ratio | 0.30 |
Current Ratio | 1.02 |
Quick Ratio | 1.01 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BIAF | |
---|---|
ROA (LTM) | -69.78% |
ROE (LTM) | -151.52% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BIAF | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.52 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.48 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BIAF | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.30 |
P/B | 4.84 |
Price/FCF | NM |
EV/R | 1.72 |
EV/Ebitda | NM |
bioAffinity Technologies, Inc. (BIAF) share price today is $0.9551
Yes, Indians can buy shares of bioAffinity Technologies, Inc. (BIAF) on Vested. To buy bioAffinity Technologies, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BIAF stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of bioAffinity Technologies, Inc. (BIAF) via the Vested app. You can start investing in bioAffinity Technologies, Inc. (BIAF) with a minimum investment of $1.
You can invest in shares of bioAffinity Technologies, Inc. (BIAF) via Vested in three simple steps:
The 52-week high price of bioAffinity Technologies, Inc. (BIAF) is $3.62. The 52-week low price of bioAffinity Technologies, Inc. (BIAF) is $0.92.
The price-to-earnings (P/E) ratio of bioAffinity Technologies, Inc. (BIAF) is
The price-to-book (P/B) ratio of bioAffinity Technologies, Inc. (BIAF) is 4.84
The dividend yield of bioAffinity Technologies, Inc. (BIAF) is 0.00%
The market capitalization of bioAffinity Technologies, Inc. (BIAF) is $19.81M
The stock symbol (or ticker) of bioAffinity Technologies, Inc. is BIAF